CorMedix, Inc. (CRMD)
8.02
+0.02
(+0.25%)
USD |
NASDAQ |
Oct 28, 10:51
CorMedix Cash from Investing (Quarterly) : -0.561M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.561M |
| March 31, 2026 | 2.965M |
| December 31, 2025 | 3.297M |
| September 30, 2025 | -291.32M |
| June 30, 2025 | -20.21M |
| March 31, 2025 | -0.1948M |
| December 31, 2024 | -0.3042M |
| September 30, 2024 | 6.321M |
| June 30, 2024 | 6.269M |
| March 31, 2024 | 8.945M |
| December 31, 2023 | 0.5978M |
| September 30, 2023 | -0.5869M |
| June 30, 2023 | -2.386M |
| March 31, 2023 | -14.69M |
| December 31, 2022 | -0.0019M |
| September 30, 2022 | -0.1143M |
| June 30, 2022 | 0.5944M |
| March 31, 2022 | -4.188M |
| December 31, 2021 | -7.129M |
| September 30, 2021 | -1.271M |
| June 30, 2021 | -0.2083M |
| March 31, 2021 | -0.526M |
| December 31, 2020 | -1.848M |
| September 30, 2020 | 3.243M |
| June 30, 2020 | 5.045M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.9854M |
| December 31, 2019 | 0.2963M |
| September 30, 2019 | -0.4772M |
| June 30, 2019 | -3.875M |
| March 31, 2019 | -7.965M |
| December 31, 2018 | 0.0001M |
| September 30, 2018 | -0.0107M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 1.566M |
| December 31, 2017 | 5.067M |
| September 30, 2017 | 4.070M |
| June 30, 2017 | -3.937M |
| March 31, 2017 | 5.158M |
| December 31, 2016 | 4.716M |
| September 30, 2016 | -0.2958M |
| June 30, 2016 | 0.4518M |
| March 31, 2016 | 6.548M |
| December 31, 2015 | 0.01M |
| September 30, 2015 | -10.22M |
| June 30, 2015 | -13.38M |
| March 31, 2015 | -0.0129M |
| December 31, 2014 | 0.0005M |
| September 30, 2014 | -0.0063M |
| June 30, 2014 | -0.0196M |
| March 31, 2014 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.021M |
| Eloxx Pharmaceuticals, Inc. | 0.00 |
| Breakthrough Chemistry, Inc. | 0.00 |
| BioStem Technologies, Inc. | -0.0561M |
| Cardiac Biotech Solutions, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 86.06M |
| Cash from Financing (Quarterly) | -6.894M |
| Free Cash Flow | 250.11M |
| Free Cash Flow Per Share (Quarterly) | 0.9245 |
| Free Cash Flow to Equity (Quarterly) | 85.23M |
| Free Cash Flow to Firm (Quarterly) | 85.50M |
| Free Cash Flow Yield | 34.12% |